Cabaletta Bio Inc (CABA)
12.34
-0.28
(-2.22%)
USD |
NASDAQ |
May 17, 16:00
12.67
+0.33
(+2.67%)
Pre-Market: 20:00
Cabaletta Bio Cash and Short Term Investments (Quarterly): 223.84M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 223.84M |
| December 31, 2023 | 241.25M |
| September 30, 2023 | 164.39M |
| June 30, 2023 | 176.33M |
| March 31, 2023 | 93.84M |
| December 31, 2022 | 106.55M |
| September 30, 2022 | 85.90M |
| June 30, 2022 | 96.81M |
| March 31, 2022 | 109.21M |
| December 31, 2021 | 122.22M |
| September 30, 2021 | 119.26M |
| Date | Value |
|---|---|
| June 30, 2021 | 102.81M |
| March 31, 2021 | 102.03M |
| December 31, 2020 | 108.66M |
| September 30, 2020 | 116.74M |
| June 30, 2020 | 119.80M |
| March 31, 2020 | 131.00M |
| December 31, 2019 | 136.20M |
| September 30, 2019 | 71.04M |
| June 30, 2019 | 75.26M |
| December 31, 2018 | 33.02M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
71.04M
Minimum
Sep 2019
241.25M
Maximum
Dec 2023
125.16M
Average
112.98M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Editas Medicine Inc | 296.17M |
| ACADIA Pharmaceuticals Inc | 470.52M |
| Alnylam Pharmaceuticals Inc | 2.371B |
| Regeneron Pharmaceuticals Inc | 10.52B |
| Vertex Pharmaceuticals Inc | 10.17B |